Research & Innovation
We spoke with Paul Fisher, Ph.D and Jiong Li, Ph.D, two Massey researchers that worked on a collaborative study that suggests a new small molecule inhibitor, IVMT-Rx-4, could open the door for enhanced targeted treatment options for head and neck squamous cell carcinoma (HNSCC)....
Research & Innovation, Prevention , Leadership
Massey is just the second NCI-designated comprehensive cancer center to earn Worta McCaskill-Stevens K12 grant. ...
Research & Innovation, Clinical Care
July is Sarcoma and Bone Cancer Awareness Month. To close the month, we spoke with Frances Austin, M.D., a pediatric oncologist at Children’s Hospital of Richmond at VCU, to learn more about the signs, symptoms and treatment options for sarcomas and bone cancers. ...
Research & Innovation
A team of scientists from Virginia Commonwealth University, VCU Massey and the University of Texas MD Cancer Center uncovered a protein, TRNAU1AP, that plays an essential role in helping glioblastoma cells survive, multiply and be more vulnerable to treatment. ...
Treatments in clinical trials may be more effective or have fewer side effects than the treatments that are currently available. With more than 200 studies for multiple types of cancers and cancer prevention, Massey supports a wide array of clinical trials.
Massey supports hundreds of top cancer specialists serving the needs of our patients. Massey’s medical team provides a wealth of expertise in cancer diagnosis, treatment, prevention and symptom management.
Massey is proud to partner with OncLive to provide interviews and videos from thought leaders and cutting edge articles and resources on cancer.